Rock Creek Group LP acquired a new stake in shares of HCA Healthcare Inc (NYSE:HCA) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 4,819 shares of the company’s stock, valued at approximately $651,000.

Several other institutional investors have also made changes to their positions in HCA. Magellan Asset Management Ltd increased its stake in shares of HCA Healthcare by 21.0% in the 2nd quarter. Magellan Asset Management Ltd now owns 15,621,068 shares of the company’s stock valued at $2,111,500,000 after purchasing an additional 2,712,130 shares in the last quarter. Schroder Investment Management Group increased its stake in shares of HCA Healthcare by 215.7% in the 2nd quarter. Schroder Investment Management Group now owns 1,328,422 shares of the company’s stock valued at $179,562,000 after purchasing an additional 907,658 shares in the last quarter. Longview Partners Guernsey LTD increased its stake in shares of HCA Healthcare by 9.4% in the 2nd quarter. Longview Partners Guernsey LTD now owns 9,487,250 shares of the company’s stock valued at $1,282,392,000 after purchasing an additional 813,474 shares in the last quarter. Camber Capital Management LP purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at about $81,102,000. Finally, Prudential Financial Inc. increased its stake in shares of HCA Healthcare by 56.0% in the 2nd quarter. Prudential Financial Inc. now owns 1,397,344 shares of the company’s stock valued at $188,879,000 after purchasing an additional 501,605 shares in the last quarter. Hedge funds and other institutional investors own 70.19% of the company’s stock.

In related news, SVP Kathleen M. Whalen sold 977 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $127.56, for a total value of $124,626.12. Following the transaction, the senior vice president now directly owns 11,484 shares in the company, valued at $1,464,899.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Robert A. Waterman sold 33,786 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $134.98, for a total value of $4,560,434.28. Following the completion of the transaction, the senior vice president now owns 279,551 shares in the company, valued at $37,733,793.98. The disclosure for this sale can be found here. Corporate insiders own 2.70% of the company’s stock.

HCA has been the topic of several research analyst reports. ValuEngine cut HCA Healthcare from a “hold” rating to a “sell” rating in a report on Tuesday. Bank of America upgraded HCA Healthcare from an “underperform” rating to a “neutral” rating and lifted their price objective for the stock from $130.00 to $137.00 in a report on Friday, September 6th. Zacks Investment Research cut HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price objective on the stock. in a report on Monday, May 27th. UBS Group lifted their price objective on HCA Healthcare from $172.00 to $181.00 and gave the stock a “buy” rating in a report on Monday, June 24th. Finally, Goldman Sachs Group upgraded HCA Healthcare from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $147.00 to $160.00 in a report on Wednesday, July 10th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. HCA Healthcare currently has a consensus rating of “Buy” and an average target price of $155.29.

Shares of HCA Healthcare stock traded down $0.13 on Wednesday, hitting $124.86. 715,082 shares of the company were exchanged, compared to its average volume of 1,329,383. The stock has a market capitalization of $42.57 billion, a price-to-earnings ratio of 12.78, a price-to-earnings-growth ratio of 1.10 and a beta of 0.87. The company has a 50-day moving average price of $125.35 and a 200 day moving average price of $128.85. HCA Healthcare Inc has a 1-year low of $110.31 and a 1-year high of $147.42.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 30th. The company reported $2.21 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $2.49 by ($0.28). The company had revenue of $12.60 billion for the quarter, compared to analyst estimates of $12.61 billion. HCA Healthcare had a negative return on equity of 135.90% and a net margin of 7.46%. The company’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.29 earnings per share. As a group, sell-side analysts predict that HCA Healthcare Inc will post 10.4 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Tuesday, September 3rd will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date of this dividend is Friday, August 30th. HCA Healthcare’s dividend payout ratio is presently 16.38%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: Why are trading ranges significant?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.